Helen Strandt
Innsbruck, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Metabolic inhibition of glutamate-cysteine ligase increases dendritic cell-mediated antitumor immunity in melanoma.
Journal: Journal for immunotherapy of cancer
Published: June 07, 2026
Targeting Langerhans cells using a modular mannosylated nucleic acid-based vaccine platform.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 30, 2025
Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma.
Journal: Journal for immunotherapy of cancer
Published: March 25, 2024
Targeting NLRP3 inhibits AML progression by inducing PERK/eIF2-mediated apoptosis.
Journal: Cell communication and signaling : CCS
Published: March 07, 2024
NLRP3 promotes allergic responses to birch pollen extract in a model of intranasal sensitization.
Journal: Frontiers in immunology
Published: February 29, 2024
Langerhans cells orchestrate apoptosis of DNA-damaged keratinocytes upon high-dose UVB skin exposure.
Journal: European journal of immunology
Published: January 19, 2024
Guidelines for preparation and flow cytometry analysis of human nonlymphoid tissue DC.
Journal: European journal of immunology
Published: December 09, 2022
Guidelines for DC preparation and flow cytometry analysis of mouse nonlymphoid tissues.
Journal: European journal of immunology
Published: January 17, 2022
Targeted delivery of a vaccine protein to Langerhans cells in the human skin via the C-type lectin receptor Langerin.
Journal: European journal of immunology
Published: October 08, 2021
Specific Protein Antigen Delivery to Human Langerhans Cells in Intact Skin.
Journal: Frontiers in immunology
Published: June 28, 2021
IL-31 transgenic mice show reduced allergen-induced lung inflammation.
Journal: European journal of immunology
Published: January 14, 2020
Last Updated: 09/26/2026